Orphazyme A/S (ORPHA.CO)

DKK 1120.0

(-2.61%)

Revenue Summary of Orphazyme A/S

  • Orphazyme A/S's latest annual revenue in 2023 was - DKK , down 0.0% from previous year.
  • Orphazyme A/S's latest quarterly revenue in 2024 Q2 was - DKK , down 0.0% from previous quarter.
  • Orphazyme A/S reported a annual revenue of - DKK in annual revenue 2022, down -100.0% from previous year.
  • Orphazyme A/S reported a annual revenue of 36.19 Million DKK in annual revenue 2021, down 0.0% from previous year.
  • Orphazyme A/S reported a quarterly revenue of - DKK for 2024 Q2, down 0.0% from previous quarter.
  • Orphazyme A/S reported a quarterly revenue of - DKK for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Orphazyme A/S (2023 - 2015)

Historical Annual Revenue of Orphazyme A/S (2023 - 2015)

Year Revenue Revenue Growth
2023 - DKK 0.0%
2022 - DKK -100.0%
2021 36.19 Million DKK 0.0%
2020 - DKK 0.0%
2019 - DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK 0.0%
2015 - DKK 0.0%

Peer Revenue Comparison of Orphazyme A/S

Name Revenue Revenue Difference
ALK-Abelló A/S 4.82 Billion DKK 100.0%
Bavarian Nordic A/S 7.05 Billion DKK 100.0%
Genmab A/S 16.47 Billion DKK 100.0%
Gubra A/S 205 Million DKK 100.0%
Novo Nordisk A/S 232.26 Billion DKK 100.0%
Pharma Equity Group A/S - DKK NaN%
Zealand Pharma A/S 342.78 Million DKK 100.0%